Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016

Go back to Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2016

Varian Medical (VAR) PT Raised to $90 at Brean Capital

July 28, 2016 10:17 AM EDT

Brean Capital analyst Jason Wittes reiterated a Buy and bumped his price target on Varian Medical (NYSE: VAR) to $90.00 (from $87.00) following Q3 results with Strong NA Oncology, Stable Imaging, and Good Margins.

Wittes commented, "VAR reported F3Q16 Adjusted EPS of $1.22 versus consensus of $1.17quality was good, with notably high gross margins.... More

Jefferies Raises Price Target on Varian Medical Systems (VAR) to $98; Reiterates Buy

July 28, 2016 9:21 AM EDT

Jefferies reiterated a Buy rating on Varian Medical Systems (NYSE: VAR), and raised the price target to $98.00 (from $95.00), following the company's 3Q report.

Analyst Anthony Petrone commented, "VAR put up a $9mn/$0.05 beat highlighted by a surge in NA Oncology orders to +15% (from +7%).... More

Varian Medical Systems (VAR) Tops Q3 EPS by 5c, Updates FY EPS Guidance

July 27, 2016 4:20 PM EDT

Varian Medical Systems (NYSE: VAR) reported Q3 EPS of $1.22, $0.05 better than the analyst estimate of $1.17. Revenue for the quarter came in at $789.4 million versus the consensus estimate of $779.98 million.

GUIDANCE:

Varian Medical Systems sees FY2016 EPS of $4.62-$4.66, versus prior... More